How We Handle GLP-1 Side Effects: Our Clinical Standard

A look inside our GLP-1 side effect management standard, from slow titration to the pain that means call us.

GLP-1 side effect management, the way we practice it, starts before you feel a symptom: we titrate the dose slowly, tell you what is normal in the first weeks, and give you a direct line to us. Most side effects of semaglutide and tirzepatide are gastrointestinal, mild to moderate, and fade as your body adapts. A rare few need a same-day call. Here is how we handle both.

What side effects are we actually talking about?

When people picture starting one of these medicines, the worry is almost always the stomach. That instinct is correct. The most common effects reported in the pivotal trials were gastrointestinal: nausea, vomiting, diarrhea, and constipation. Nausea is the one we see most. In the STEP program, roughly 44 percent of people on semaglutide 2.4 mg reported nausea at some point, compared with about 25 percent on placebo. With tirzepatide, nausea ran roughly 24 to 39 percent depending on the dose.

I want to sit with those numbers for a second, because they are easy to misread. A figure like 44 percent does not mean you will spend your days nauseated. It means that across a large group, over many months, that share reported nausea at least once, and for most it was mild and passing. The placebo numbers matter too: a real slice of people feel queasy on nothing at all, which is a useful reminder that not every symptom is the medicine.

When do these effects show up, and when do they ease?

There is a pattern to this, and knowing it changes how it feels. Gastrointestinal effects tend to peak in the first one to four weeks after each dose increase, then improve as the body adapts. So the rough weeks are usually not random. They cluster right after a step up, and they tend to settle within a few weeks if the dose holds steady.

That single fact is the foundation of our whole approach. If discomfort predictably follows a dose increase and predictably fades, then the pace of those increases is the lever we can pull.

Why do you titrate the dose so slowly?

Slow dose titration is our main tool, and it is not a formality. Starting low and stepping up gradually gives your gut time to adjust between increases, which is exactly what the trial data would predict. When someone is having a hard week, the answer is often not a new medication or a fistful of remedies. It is simply to hold the current dose longer, or to step back, and let the body catch up before we move again.

We would rather you reach a comfortable, effective dose a few weeks later than push a schedule that leaves you miserable and tempted to quit. Getting there slowly and staying there beats getting there fast and stopping. Because these are compounded semaglutide and compounded tirzepatide, which are not FDA-approved and not identical to the brand-name drugs, and results vary, we are especially deliberate about pacing and follow-up.

What can you do at home for nausea and constipation?

Most of what helps is not a prescription. A handful of ordinary habits take the edge off the common effects, and they are the same steps used in the trials and in good clinical practice.

• Eat smaller meals. These medicines slow how quickly your stomach empties, so a large plate sits heavier than it used to. Smaller portions, more often, tend to feel better.
• Eat slowly and stop at comfortable. Fullness arrives sooner and hits harder now. Give it time to register, and put the fork down a little earlier than your old habit says.
• Stay hydrated. Steady fluids through the day help with nausea and are your first move against constipation.
• Add fiber for constipation. Vegetables, fruit, whole grains, and a fiber supplement when needed keep things moving. Pair fiber with water, not without it.

Bland, lower-fat, lower-odor foods during a rough stretch tend to sit easiest. None of this is exotic. It is just tuned to how the medicine changes your digestion.

When should you call us?

Part of handling side effects well is being honest about which ones are ordinary and which ones are not. Call us if nausea, vomiting, or diarrhea is severe enough that you cannot keep fluids down, if symptoms are not settling the way we described, or if anything simply worries you. That last one is not a throwaway line. A quick message often saves a bad week, and we would always rather hear from you early.

There is one symptom we flag above all others. Uncommon but serious risks with this class include pancreatitis and gallbladder problems. The warning sign to know is severe, persistent abdominal pain, sometimes spreading to the back, often with vomiting. That is not a wait-and-see symptom. Contact a clinician promptly, and if it is severe, seek urgent care. These events are uncommon, and knowing the one signal to act on is exactly what keeps a rare problem from becoming a serious one.

How do you adjust the plan for me specifically?

No two people move through this the same way. One person sails through titration and barely notices; another needs to spend an extra month at a lower dose. Both are normal, and neither is doing it wrong. Weight and how the body responds are biology, not willpower, and the plan should bend to the person rather than the other way around.

So when we adjust, we are usually working a few dials. We change the pace, holding or stepping back a dose when your gut needs more time. We revisit the everyday habits above, since small changes there often solve more than any medication tweak. We check in on timing, hydration, and fiber. And we keep asking how you actually feel, because a plan you can live with is the only one that works over the long run. This is a relationship, not a single prescription handed over at the door.

What does this look like at New Hope?

Our care is telehealth, cash-pay, bilingual, and private, with no insurance needed, and Dr. Anjmun Sharma, MD leads it. Practically, that means you can reach us without a waiting room and without a claims runaround when a symptom shows up. A first visit is $119. Compounded semaglutide is $166 a month, about $5.50 a day, with a 90-day Reset at $499. Compounded tirzepatide is $233 a month, about $7.70 a day, with a 90-day Reset at $699. If you want to test the waters, the $199 Skeptics Trial covers one month and is a low-commitment way to see how your body responds before deciding on more.

The honest promise here is not that you will feel nothing. It is that the common effects are usually manageable, that we know when they should ease, that we pace the medicine to keep them small, and that when the one serious signal appears we want to hear from you right away. That is what handling side effects well actually means. When a brand drug comes up in conversation, note that Ozempic and Wegovy are Novo Nordisk products and Mounjaro and Zepbound are Eli Lilly products; we are not affiliated with either company.

If you are weighing whether this is right for you, reach us in English at (657) 837-3342 or in Spanish at (213) 214-3325. We are at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626.

Frequently asked questions

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.